Brief: Gain Therapeutics Q2 Loss Per Share $0.30
11/08/2021 22:02
Aug 11 (Reuters) - Gain Therapeutics Inc GANX.O :
* GAIN THERAPEUTICS, INC. REPORTS SECOND QUARTER 2021
FINANCIAL
RESULTS AND BUSINESS UPDATE
* Q2 GAAP LOSS PER SHARE $0.30
* $43.2 MILLION IN CASH AS OF JUNE 30, 2021, PROVIDES RUNWAY
INTO
SECOND HALF OF 2023
Source text for Eikon: ID:nGNX7V2lLG
Further company coverage: GANX.O
Recent news on Gain Therapeutics
See all newsU.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
Gain Therapeutics climbs on narrower-than-expected quarterly loss
Gain Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Gain Therapeutics Q2 net loss per share narrows as R&D expenses fall